Literature DB >> 1700054

Lack of N regions in fetal and neonatal mouse immunoglobulin V-D-J junctional sequences.

A J Feeney1.   

Abstract

Much of T and B lymphocyte receptor diversity derives from the addition of nontemplated N regions at the junctions of receptor gene elements, although fetal T cells expressing gamma/delta receptors lack N regions. I have sequenced immunoglobulin H chain variable regions of PCR-amplified DNA and cDNA from fetal and newborn mouse liver and spleen cells. These sequences showed an absence of N regions. Only 1/87 DNA sequences and 17/146 RNA sequences contained N regions, in striking contrast to adult Ig sequences. These data show that N region insertion is a developmentally regulated process in B cells as well as in T cells, and demonstrate that receptor diversity in neonatal B cells is limited by the absence of N regions as well as by biased usage of Vh genes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1700054      PMCID: PMC2188672          DOI: 10.1084/jem.172.5.1377

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  56 in total

1.  Lymphoid V(D)J recombination: nucleotide insertion at signal joints as well as coding joints.

Authors:  M R Lieber; J E Hesse; K Mizuuchi; M Gellert
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

2.  Diversity and joining segments of mouse immunoglobulin heavy chain genes are closely linked and in the same orientation: implications for the joining mechanism.

Authors:  C Wood; S Tonegawa
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

3.  The expression of a set of antibody variable regions in lipopolysaccharide-reactive B cells at various stages of ontogeny and its control by anti-idiotypic antibody.

Authors:  S Nishikawa; T Takemori; K Rajewsky
Journal:  Eur J Immunol       Date:  1983-04       Impact factor: 5.532

4.  Two types of somatic recombination are necessary for the generation of complete immunoglobulin heavy-chain genes.

Authors:  H Sakano; R Maki; Y Kurosawa; W Roeder; S Tonegawa
Journal:  Nature       Date:  1980-08-14       Impact factor: 49.962

5.  A single VH gene segment encodes the immune response to phosphorylcholine: somatic mutation is correlated with the class of the antibody.

Authors:  S Crews; J Griffin; H Huang; K Calame; L Hood
Journal:  Cell       Date:  1981-07       Impact factor: 41.582

6.  Ontogeny of terminal deoxynucleotidyl transferase-positive cells in lymphohemopoietic tissues of rat and mouse.

Authors:  K E Gregoire; I Goldschneider; R W Barton; F J Bollum
Journal:  J Immunol       Date:  1979-09       Impact factor: 5.422

7.  Multiple immunoglobulin heavy-chain gene transcripts in Abelson murine leukemia virus-transformed lymphoid cell lines.

Authors:  F W Alt; N Rosenberg; V Enea; E Siden; D Baltimore
Journal:  Mol Cell Biol       Date:  1982-04       Impact factor: 4.272

8.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

9.  Frequencies of mitogen-reactive B cells in the mouse. I. Distribution in different lymphoid organs from different inbred strains of mice at different ages.

Authors:  J Andersson; A Coutinho; F Melchers
Journal:  J Exp Med       Date:  1977-06-01       Impact factor: 14.307

10.  Organization, structure, and assembly of immunoglobulin heavy chain diversity DNA segments.

Authors:  Y Kurosawa; S Tonegawa
Journal:  J Exp Med       Date:  1982-01-01       Impact factor: 14.307

View more
  123 in total

Review 1.  Factors that influence formation of B cell repertoire.

Authors:  A J Feeney
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

Review 2.  Relative roles of somatic and Darwinian evolution in shaping the antibody response.

Authors:  M Diaz; N R Klinman
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

3.  Third complementarity-determining region of mutated VH immunoglobulin genes contains shorter V, D, J, P, and N components than non-mutated genes.

Authors:  K Rosner; D B Winter; R E Tarone; G L Skovgaard; V A Bohr; P J Gearhart
Journal:  Immunology       Date:  2001-06       Impact factor: 7.397

4.  Developmental heterogeneity of V gamma 1.1 T cells in the mouse liver.

Authors:  Y Kodaira; K Yokomuro; S Tanaka; J I Miyazaki; K Ikuta
Journal:  Immunology       Date:  1996-02       Impact factor: 7.397

5.  Three lymphoid-specific factors account for all junctional diversity characteristic of somatic assembly of T-cell receptor and immunoglobulin genes.

Authors:  S Kallenbach; N Doyen; M Fanton d'Andon; F Rougeon
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

Review 6.  Regulation of the antibody repertoire through control of HCDR3 diversity.

Authors:  H W Schroeder; G C Ippolito; S Shiokawa
Journal:  Vaccine       Date:  1998 Aug-Sep       Impact factor: 3.641

7.  Comparable profiles of the immunoglobulin heavy chain complementarity determining region (CDR)-3 in CD5+ and CD5- human cord blood B lymphocytes.

Authors:  H Kiyoi; K Naito; R Ohno; T Naoe
Journal:  Immunology       Date:  1995-06       Impact factor: 7.397

8.  Terminal deoxynucleotidyl transferase is required for an optimal response to the polysaccharide α-1,3 dextran.

Authors:  Tamer I Mahmoud; John F Kearney
Journal:  J Immunol       Date:  2009-12-16       Impact factor: 5.422

9.  Immunoglobulin light chain variable region gene sequences for human antibodies to Haemophilus influenzae type b capsular polysaccharide are dominated by a limited number of V kappa and V lambda segments and VJ combinations.

Authors:  E E Adderson; P G Shackelford; R A Insel; A Quinn; P M Wilson; W L Carroll
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

10.  Characterization of the immunoglobulin heavy chain complementarity determining region (CDR)-III sequences from human B cell precursor acute lymphoblastic leukemia cells.

Authors:  H Kiyoi; T Naoe; K Horibe; R Ohno
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.